BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 8986943)

  • 1. Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles.
    Tencza MG; Newbold JE
    J Med Virol; 1997 Jan; 51(1):6-16. PubMed ID: 8986943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Korolowicz KE; Suresh M; Li B; Huang X; Yon C; Kallakury BV; Lee KP; Park S; Kim YW; Menne S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.
    Menne S; Tumas DB; Liu KH; Thampi L; AlDeghaither D; Baldwin BH; Bellezza CA; Cote PJ; Zheng J; Halcomb R; Fosdick A; Fletcher SP; Daffis S; Li L; Yue P; Wolfgang GH; Tennant BC
    J Hepatol; 2015 Jun; 62(6):1237-45. PubMed ID: 25559326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks.
    Freitas N; Lukash T; Dudek M; Litwin S; Menne S; Gudima SO
    Virus Res; 2015 Jul; 205():12-21. PubMed ID: 25979221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks.
    Suresh M; Korolowicz KE; Balarezo M; Iyer RP; Padmanabhan S; Cleary D; Gimi R; Sheri A; Yon C; Kallakury BV; Tucker RD; Afdhal N; Menne S
    PLoS One; 2017; 12(1):e0169631. PubMed ID: 28056062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obelisks - Newly discovered virus-like particles.
    Soriano V; Moreno-Torres V; Corral O
    AIDS Rev; 2024 Mar; ():. PubMed ID: 38442329
    [No Abstract]   [Full Text] [Related]  

  • 7. Virion Secretion of Hepatitis B Virus Naturally Occurring Core Antigen Variants.
    Shih C; Wu SY; Chou SF; Yuan TT
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of Hepatitis B Virus DNA and the Tempos between Virion Secretion and Genome Maturation in a Mouse Model.
    Wu SY; Chang YS; Chu TH; Shih C
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.
    Hu J; Liu K
    Viruses; 2017 Mar; 9(3):. PubMed ID: 28335554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus.
    Chua PK; Wang RY; Lin MH; Masuda T; Suk FM; Shih C
    J Virol; 2005 Nov; 79(21):13483-96. PubMed ID: 16227269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173).
    Le Pogam S; Chua PK; Newman M; Shih C
    J Virol; 2005 Feb; 79(3):1871-87. PubMed ID: 15650211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of two distinct secretion mutations (P5T and I97L) in hepatitis B virus core produces a wild-type pattern of secretion.
    Chua PK; Wen YM; Shih C
    J Virol; 2003 Jul; 77(13):7673-6. PubMed ID: 12805468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duck hepatitis B virus virion secretion requires a double-stranded DNA genome.
    Perlman D; Hu J
    J Virol; 2003 Feb; 77(3):2287-94. PubMed ID: 12525667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus.
    Suk FM; Lin MH; Newman M; Pan S; Chen SH; Liu JD; Shih C
    J Virol; 2002 Dec; 76(23):12069-77. PubMed ID: 12414948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication.
    Addison WR; Walters KA; Wong WW; Wilson JS; Madej D; Jewell LD; Tyrrell DL
    J Virol; 2002 Jun; 76(12):6356-63. PubMed ID: 12021368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L).
    Yuan TT; Shih C
    J Virol; 2000 May; 74(10):4929-32. PubMed ID: 10775637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen.
    Yuan TT; Sahu GK; Whitehead WE; Greenberg R; Shih C
    J Virol; 1999 Jul; 73(7):5731-40. PubMed ID: 10364324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection.
    Genovesi EV; Lamb L; Medina I; Taylor D; Seifer M; Innaimo S; Colonno RJ; Standring DN; Clark JM
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3209-17. PubMed ID: 9835516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.
    Seifer M; Hamatake RK; Colonno RJ; Standring DN
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3200-8. PubMed ID: 9835515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
    Cullen JM; Smith SL; Davis MG; Dunn SE; Botteron C; Cecchi A; Linsey D; Linzey D; Frick L; Paff MT; Goulding A; Biron K
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2076-82. PubMed ID: 9333028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.